For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251103:nRSC7940Fa&default-theme=true
RNS Number : 7940F Tooru PLC 03 November 2025
3 November 2025
Tooru Plc
("Tooru" or the "Company")
focusIR Investor Interview
Tooru (AIM: TOO), a company specialising in the health and wellness sector,
announces that
Joe Mitchell, Managing Director of Juvela - its leading gluten-free brand
which recently introduced a new retail offering - has published an investor
focused interview with focusIR.
The interview can be accessed on the London South East platform
(https://www.lse.co.uk/SharePrice.html?shareprice=TOO&share=Tooru) or
watched here:
https://media.focusir.com/InsideTooru-Juvella
(https://media.focusir.com/InsideTooru-Juvella)
For further information, please contact:
Tooru plc Via focusIR
Scott Livingston, CEO
Digital IR - focusIR Tel:+44 (0) 20 4570 2250
Kat Perez kat.perez@focusir.com (mailto:kat.perez@focusir.com)
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed
at assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases into the public domain.
Information required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an RNS
regulatory announcement and not on Reach.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAQLLFBEFLZFBE
Copyright 2019 Regulatory News Service, all rights reserved